A novel aminoglycoside antibiotic is developed that is intravenously administered and excreted unchanged in urine with an elimination half-life of 4 hours. Two different dosing regimens are tested in a clinical trial: smaller doses given 3 times a day and a higher dose given once a day. The total administered drug amount per kilogram of body weight per day (mg/kg/day) is the same in both regimens. Serum drug concentration is monitored in both groups and is shown in the graph below:[Blue: once-daily (extended interval) dosing, Green: multiple-daily dosing, MIC: minimum inhibitory concentration]
It is found that both regimens are effective against gram-negative pathogens, with clinical improvement occurring slightly earlier on average with once-daily dosing. Which of the following best explains the efficacy of once-daily dosing despite the short half-life of this antibiotic?
A) Concentration-dependent killing
B) High therapeutic index
C) Linear dose-response relationship
D) Low threshold dose
E) Time-dependent killing
Correct Answer:
Verified
Q261: A 64-year-old man comes to the office
Q262: A 70-year-old man is diagnosed with a
Q263: A 50-year-old woman comes to the emergency
Q264: A 32-year-old man with HIV is diagnosed
Q265: A 5-year-old girl is brought to the
Q267: A 32-year-old woman comes to the physician
Q268: A 23-year-old woman comes to the emergency
Q269: A 78-year-old woman comes to the office
Q270: A 65-year-old man comes to the emergency
Q271: A 28-year-old woman comes to the office
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents